L-Theanine Meta-Analysis Evidence Review

Last updated: October 4, 2026 - Reviewed by Verdant Wellness Editorial Team

RD

By Gabriela Mitchell, Registered Dietitian (Linkedin)

Last Updated September 2026  ·  21 min read

10% off · weekly tips

Real science on cortisol, stress, and sleep.

Send it →

---

Table of Contents

1. Why Meta-Analysis Evidence Matters for L-Theanine
2. What Is L-Theanine? A Brief Scientific Background
3. L-Theanine and Sleep: What the 2024–2026 Meta-Analyses Found
4. L-Theanine and Cognitive Performance: Pooled Evidence Review
5. L-Theanine and Anxiety, Stress, and Mood: Synthesized Findings
6. L-Theanine in Clinical Populations: Mental Health Systematic Review
7. Dosage, Safety, and Tolerability Across Reviewed Studies
8. Certainty of Evidence: What the Reviewers Actually Concluded
9. Frequently Asked Questions
10. Summary and Bottom Line

---

Why Meta-Analysis Evidence Matters for L-Theanine

Single studies can mislead. A trial with 30 participants, a convenient sample, and a novel outcome measure can produce dramatic positive results—and just as easily fail to replicate the next year. This is why the scientific community uses systematic reviews and meta-analyses: they pool results across multiple trials, apply formal statistical methods, and give us a far more reliable picture of what a compound actually does, how large the effects really are, and where the evidence is still too thin to draw firm conclusions.

The L-theanine meta-analysis evidence review landscape has changed significantly between 2024 and 2026. Several high-quality pooled analyses have now been published covering sleep, cognition, anxiety, stress, and psychiatric symptoms. If you have been searching for a single resource that synthesizes all of that work—instead of cherry-picking individual trials—you are in the right place.

This article does three things that most supplement blogs do not:

• It reports exact effect sizes (standardized mean differences, confidence intervals, p-values) as published in the reviewed papers.
• It faithfully communicates certainty of evidence ratings even when they are unflattering to L-theanine's marketing image.
• It distinguishes clearly between what the data support and what remains speculative.

No supplement should be evaluated on press releases and manufacturer white papers. This review evaluates L-theanine on the same standard clinicians use: the peer-reviewed theanine systematic review and meta-analysis literature.

---

What Is L-Theanine? A Brief Scientific Background

L-theanine (γ-glutamylethylamide) is a non-protein amino acid found almost exclusively in tea leaves (Camellia sinensis) and in certain mushrooms. It was first isolated from green tea in Japan in 1949. In the context of everyday tea drinking, a standard cup of green tea delivers roughly 20–40 mg of L-theanine; matcha can deliver considerably more.

Pharmacologically, L-theanine crosses the blood-brain barrier and is thought to exert effects through several overlapping mechanisms:

• Glutamate receptor modulation: Structural similarity to glutamate allows partial antagonism at NMDA and AMPA receptors, potentially tempering excitatory neurotransmission.
• GABA and glycine enhancement: Animal studies suggest upregulation of inhibitory neurotransmitters.
• Alpha-wave induction: EEG studies have consistently shown increases in alpha-wave activity (8–12 Hz) within 30–90 minutes of oral dosing, a pattern associated with relaxed wakefulness.
• Dopamine and serotonin modulation: Indirect effects on monoamine systems have been proposed, though the evidence in humans remains preliminary.

In clinical research, L-theanine has most commonly been studied at doses of 100–400 mg, either as a single acute dose or taken daily over weeks. The majority of the recent theanine clinical review literature uses 200 mg as the benchmark dose, largely because this is approximately the lowest dose shown to reliably produce alpha-wave changes and because 200 mg represents a commercially standardized unit.

Before we dive into the pooled findings, one conceptual clarification is important: L-theanine is frequently co-administered with caffeine in research protocols. Results from L-theanine alone versus L-theanine plus caffeine are not interchangeable, and this review will distinguish between them wherever the source data allow.

---

L-Theanine and Sleep: What the 2024–2026 Meta-Analyses Found

Sleep is the outcome domain where the L-theanine evidence base is, at this point, the most mature and the most rigorously synthesized.

The 2024 Sleep Medicine Reviews Meta-Analysis

The most comprehensive single piece of evidence is a 2024 systematic review and meta-analysis published in Sleep Medicine Reviews, which conducted a thorough search and ultimately identified 19 articles meeting inclusion criteria, with 18 studies entering the formal meta-analysis and a combined sample of N = 897 participants [1].

The statistical results for subjective sleep outcomes were as follows:

| Outcome Domain | SMD | 95% CI | p-value | Studies (k) | |---|---|---|---|---| | Sleep onset latency (subjective) | 0.15 | 0.01–0.29 | 0.04 | 10 | | Daytime dysfunction (subjective) | 0.33 | 0.16–0.49 | <0.001 | 9 | | Overall sleep quality (subjective) | 0.43 | 0.04–0.83 | 0.03 | 12 |

To interpret these figures correctly: an SMD of 0.15 for sleep onset latency is small by conventional benchmarks (Cohen's d < 0.2). The improvement in daytime dysfunction (SMD 0.33) reaches the small-to-medium range, and the overall sleep quality improvement (SMD 0.43) edges toward medium. All three confidence intervals exclude zero, indicating these results are unlikely to be chance findings at conventional alpha levels—though the confidence interval for overall sleep quality is notably wide (0.04–0.83), which reflects meaningful heterogeneity across trials.

What this tells us clinically: L-theanine appears to produce modest, real-world improvements in how people experience their sleep. The effect on getting to sleep is small, the effect on feeling functional during the day is more substantial, and the overall quality rating sits in between. These are not dramatic, pharmaceutical-level effect sizes—but they are consistently positive and statistically significant across a large pooled sample.

The 2025 Meta-Analysis: 13 Trials, N = 550

A second independent meta-analysis published in 2025 identified 13 eligible trials with a combined n = 550 participants and reached a complementary conclusion: 200–450 mg per day of L-theanine appears safe and effective for supporting healthy sleep in adults [4]. This dose range aligns almost exactly with what the 2024 review found to be most commonly studied and most consistently beneficial.

Is L-Theanine Better for Sleep Onset, Maintenance, or Daytime Functioning?

Based on the pooled data, the daytime dysfunction domain (SMD 0.33) shows the most robust effect in the 2024 meta-analysis. This suggests that L-theanine's primary sleep-related mechanism may not be sedation per se—which is consistent with the fact that L-theanine does not meaningfully increase total sleep time in most trials—but rather a qualitative improvement in sleep architecture that translates into better daytime performance and reduced sleepiness.

The sleep onset latency finding (SMD 0.15, p=0.04) is statistically significant but modest enough that individual variation will determine whether a given person experiences a noticeable difference.

★★★★★ 4.8 · 1,247 reviews

Feel Calm By Bedtime. Focused By Morning.

Adaptogen-based formula. Third-party tested. Made in an FDA-registered facility. Backed by a 60-day money-back guarantee.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

L-Theanine and Cognitive Performance: Pooled Evidence Review

The l-theanine cognitive meta literature is a more complicated story. Three separate pooled analyses have examined cognitive outcomes between 2025 and 2026, and while all of them found some benefit, each also noted meaningful limitations that deserve full disclosure.

The 2025 Systematic Review: Dose-Dependent Cognitive Effects

A 2025 systematic review and meta-analysis titled "Promising, but Not Completely Conclusive" examined 5 RCTs involving 148 healthy adults [2]. The central finding: acute L-theanine administration produced a dose-dependent effect on cognitive function, with the clearest signal appearing in rapid visual information processing and recognition visual reaction time. The pooled effect on visual reaction time was a mean difference of −15.20 ms (95% CI: −28.99 to −1.41)—meaning participants responded approximately 15 milliseconds faster after L-theanine compared to placebo.

Fifteen milliseconds may sound trivial, but in the context of sustained attention tasks this represents a meaningful improvement. Critically, the authors rated the certainty of evidence as low to very low, primarily because of:

• Small individual sample sizes in the constituent trials
• Heterogeneity in cognitive tests used across studies
• Risk of bias concerns in some RCTs
• Inconsistency in dosing protocols

The 2026 Comprehensive Meta-Analysis: 31 Randomized Trials

The most ambitious piece of l-theanine evidence synthesis on cognitive and affective outcomes is a 2026 systematic review and meta-analysis that synthesized data from 31 randomized trials [3]. Key findings:

• Choice reaction time: A single 200 mg dose taken 30–60 minutes before testing improved performance with SMD = 0.51 (95% CI: 0.25–0.77). This is a medium-to-large effect size and represents the strongest positive cognitive finding in the entire L-theanine pooled analysis literature.
• Acute stress reduction: The pooled effect was modest at SMD = 0.31—statistically detectable but not large.
• Fatigue: No significant effect was observed in the pooled analysis.

The choice reaction time finding is particularly noteworthy. An SMD of 0.51 means participants who took 200 mg of L-theanine roughly 30–60 minutes prior to testing performed about half a standard deviation better on choice reaction time than those who took placebo. That is a clinically meaningful difference in attentional tasks.

Does L-Theanine Need Caffeine to Work Cognitively?

A long-standing debate in this field concerns whether the cognitive benefits of L-theanine require co-administration with caffeine. The theanine research review literature does not fully resolve this, but the 2026 31-trial meta-analysis included both combination and standalone protocols and still found significant effects for L-theanine alone on reaction time outcomes. This does not mean caffeine is irrelevant—several sub-analyses suggest synergistic effects—but it does suggest that L-theanine alone is not cognitively inert.

Healthy Adults Only?

Both major cognitive meta-analyses focused exclusively on healthy adults. There is currently insufficient pooled data on cognitive effects in populations with specific cognitive disorders, neurodegenerative disease, or developmental conditions to draw separate conclusions.

★★★★★ 4.8 · 1,247 reviews

The Adaptogens Your Nervous System Has Been Missing.

Ashwagandha, rhodiola, and phosphatidylserine — clinically-studied ingredients that support healthy cortisol rhythms.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

L-Theanine and Anxiety, Stress, and Mood: Synthesized Findings

The theanine anxiety meta evidence is, frankly, the most heterogeneous and the hardest to summarize cleanly. This is partly because anxiety is not one thing—trait anxiety, state anxiety, acute stress reactivity, and social anxiety have different neurobiological substrates and respond differently to interventions—and partly because the outcome measures used across L-theanine trials vary enormously.

What the 2026 Meta-Analysis Found on Stress

The 2026 comprehensive analysis (31 RCTs) found that a 200 mg dose produced a modest but detectable reduction in acute stress: SMD = 0.31 [3]. This effect is real in a statistical sense but small in a clinical sense. For context, approved pharmacological anxiolytics typically produce effect sizes in the range of 0.5–1.2 on validated anxiety scales in head-to-head trials against placebo.

An SMD of 0.31 means L-theanine reduced stress ratings by roughly a third of a standard deviation versus placebo. Whether this is clinically meaningful depends on the individual and the context. For someone experiencing mild, situational stress—the kind that most healthy adults report—this may represent a perceptible difference in subjective state. For someone meeting diagnostic criteria for generalized anxiety disorder, it is unlikely to be sufficient as a standalone intervention.

Crucially, no significant effect on fatigue was found in the same pooled analysis. This partially addresses a concern some clinicians have raised: that any apparent anxiolytic effect might simply reflect sedation. The absence of a fatigue effect argues against this interpretation.

Anxiolytic Effects in the Broader Evidence Base

The theanine systematic literature on anxiety more broadly includes both standalone trials and combination studies. Key patterns from the l-theanine pooled analysis framework:

• Trait anxiety: Effects are weak and inconsistent across trials. L-theanine is unlikely to meaningfully alter chronic, baseline anxiety in healthy adults at standard doses.
• State anxiety (acute): More consistent small-to-moderate effects, particularly when L-theanine is taken 30–60 minutes before a defined stressor.
• Physiological stress markers: Some trials report reductions in heart rate and salivary cortisol, but pooled effect sizes for these endpoints have not reached statistical significance across all meta-analyses.
• Mood: Mixed findings. The 2026 analysis found no significant pooled effect on mood outcomes, though individual trial data are more variable.

The Alpha-Wave Mechanism and Anxiety

One mechanistic note worth including: the well-replicated finding that L-theanine increases alpha-wave activity in the EEG within 30–90 minutes of ingestion is broadly consistent with a "calm without drowsiness" pharmacological profile. Alpha waves are associated with relaxed, alert states—the mental equivalent of quietly focusing on a pleasant task. This EEG signature may be the neurophysiological correlate of the modest stress-reduction effects seen in pooled analyses.

L-Theanine in Clinical Populations: Mental Health Systematic Review

While most of the meta-analysis literature focuses on healthy adults, a 2024 systematic review examined L-theanine's effects specifically in patients with diagnosed mental health conditions [5]. This is important context for the l-theanine overall evidence picture.

What the 2024 Mental Health Review Found

The review included 11 studies drawn from six countries and covered three primary diagnostic groups: schizophrenia, anxiety disorders, and ADHD. The overall conclusion was that L-theanine appeared to reduce symptoms compared to control conditions across all three disorder categories [5].

However, several important caveats apply:

Sample sizes were small. With 11 studies total across three diagnostic categories, the per-category evidence base is thin. This is not a limitation of the reviewers' methodology—it reflects the actual state of the research.

Adjunctive use, not monotherapy. In the schizophrenia studies, L-theanine was almost always studied as an add-on to antipsychotic medication, not as a replacement. The beneficial effects observed cannot be attributed to L-theanine alone acting on the disorder.

Outcome heterogeneity. The measures used to capture "symptom reduction" varied substantially across studies—a common challenge in psychiatric research that makes pooling difficult.

Publication bias risk. As with many nutritional supplement reviews, the likelihood that null results from small trials went unpublished is non-trivial.

The finding of potential benefits in anxiety disorders is the most directly relevant to readers who want to know whether L-theanine has evidence in clinical (not just sub-clinical) anxiety. The short answer: there is a signal, but it is based on a small evidence base and should not be interpreted as supporting L-theanine as a substitute for evidence-based anxiety treatments.

The ADHD findings are intriguing but require far more research. The available trials are too few and too heterogeneous to draw reliable conclusions.

★★★★★ 4.8 · 1,247 reviews

See Why Athletes And Executives Take It Daily.

Adaptogen-based formula, third-party tested, made in the USA. Cancel subscription anytime.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Dosage, Safety, and Tolerability Across Reviewed Studies

What Doses Were Used in Meta-Analyses?

The dosing picture across the theanine clinical review literature is relatively consistent:

• Most commonly studied dose: 200 mg (used in the majority of acute cognitive and anxiety trials)
• Sleep-focused trials: 200–450 mg/day
• Range across all included trials: 100–900 mg (outliers exist, but 100–400 mg covers the vast majority)
• Duration: Single doses (acute) to 28-day supplementation in chronic studies

The 2024 and 2025 sleep meta-analyses both conclude that 200–450 mg/day appears effective for sleep outcomes and is safe for healthy adults [1, 4]. The 2026 cognitive meta-analysis identifies 200 mg, taken 30–60 minutes before cognitive testing, as the dose with the clearest evidence base [3].

Safety Data from the 2024 RCT

A 2024 randomized, double-blind, placebo-controlled clinical trial evaluating a standardized L-theanine form (AlphaWave®) in healthy adults with moderate stress over 28 days found that supplementation was safe and well tolerated, with no clinically significant adverse events reported [6]. This aligns with the broader safety profile across all included meta-analyses: L-theanine does not appear to cause significant adverse effects at the doses studied.

Known Cautions and Gaps

• Drug interactions: L-theanine may potentiate antihypertensive medications (theoretical, based on blood pressure effects seen in some trials). Clinical significance is unclear.
• Pregnancy and lactation: Insufficient data to make safety recommendations.
• Very high doses: Doses above 600–900 mg have been studied in very few human trials. Long-term safety at these levels is not established.
• Regulatory status: L-theanine is classified as Generally Recognized as Safe (GRAS) in the United States.

Certainty of Evidence: What the Reviewers Actually Concluded

Any honest l-theanine evidence synthesis must include what the reviewers themselves said about the strength of their conclusions. This is where supplemental marketing and actual science most often diverge.

The 2025 Cognitive Meta-Analysis: Low to Very Low Certainty

The 2025 meta-analysis on cognitive outcomes was explicit: certainty of evidence was rated as low to very low for the pooled findings [2]. The authors cited small trial sample sizes, heterogeneity in cognitive instruments, and risk of bias in constituent studies. This means that while the effects found (including the 15 ms reaction time improvement) are statistically significant, they should be interpreted cautiously because the underlying trial quality limits confidence in their reliability.

The 2026 Affective Meta-Analysis: Promising but Hedged

The 2026 comprehensive 31-trial meta-analysis found a medium-sized effect on choice reaction time (SMD 0.51), but the authors similarly cautioned that heterogeneity across studies was significant and that findings in some subdomains (mood, fatigue) were inconsistent [3]. The certainty ratings were not uniformly high.

The 2024 Sleep Meta-Analysis: Small but Consistent Effects

The Sleep Medicine Reviews 2024 paper is arguably the most methodologically rigorous of the group [1]. The wide confidence interval for overall sleep quality (SMD 0.43; 95% CI 0.04–0.83) signals that while the point estimate is encouraging, the uncertainty range is large enough that the true effect could be quite small or meaningfully moderate. The authors appropriately flagged this.

What "Low Certainty Evidence" Actually Means

In the GRADE framework used by most systematic reviewers, low certainty does not mean "the treatment doesn't work." It means the true effect might be substantially different from the estimated effect. Low certainty evidence can be upgraded over time as larger, better-designed trials accumulate. For L-theanine, the directional consistency across multiple independent meta-analyses—all pointing toward modest positive effects in sleep, attention, and acute stress—is genuinely encouraging, even if individual certainty ratings remain modest.

In plain language: the current l-theanine overall evidence picture suggests real but small-to-moderate effects that are probably genuine, probably not placebo artifacts at the meta-analytic level, and probably not as large as supplement marketing suggests.

★★★★★ 4.8 · 1,247 reviews

Ready To Try Adaptogen-Based Cortisol Support?

Third-party tested. 60-day guarantee. Free shipping over $40. Ships in 24 hours.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Frequently Asked Questions

Does L-theanine actually improve sleep quality?

Yes, based on pooled data. The 2024 l-theanine meta-analysis published in Sleep Medicine Reviews analyzed 18 studies with 897 participants and found statistically significant improvements in subjective sleep onset latency (SMD 0.15), daytime dysfunction (SMD 0.33), and overall sleep quality (SMD 0.43) [1]. A separate 2025 meta-analysis of 13 trials (n=550) reached the same conclusion [4]. The effects are real but modest—L-theanine is not a pharmaceutical sleep aid.

What dose of L-theanine was used in meta-analyses?

The most commonly studied dose across the pooled literature is 200 mg. Sleep studies have used 200–450 mg/day. The 2026 cognitive and affective meta-analysis identified 200 mg taken 30–60 minutes before testing as the dose with the strongest reaction time evidence [3]. No meta-analysis to date has found clear superiority for doses above 450 mg in healthy adults.

Is L-theanine better for sleep onset, sleep maintenance, or daytime functioning?

Based on the 2024 theanine systematic review and meta-analysis, the daytime dysfunction domain shows the most robust pooled effect (SMD 0.33, p<0.001). Sleep onset latency improvement is statistically significant but smaller (SMD 0.15). Sleep maintenance is less consistently reported across included trials, making it harder to draw pooled conclusions. The emerging picture suggests L-theanine may improve sleep quality without strongly increasing sedation—which fits its known alpha-wave mechanism.

Does L-theanine help anxiety or stress, and how strong is the evidence?

The 2026 comprehensive meta-analysis (31 RCTs) found a modest pooled reduction in acute stress: SMD = 0.31 [3]. This is a small-to-medium effect—real, but not comparable to approved anxiolytics. Importantly, no significant effect on fatigue was found, suggesting the stress reduction is not simply sedation. Evidence in clinically diagnosed anxiety disorders is limited to 11 studies across a 2024 systematic review, and certainty remains low.

Is L-theanine safe for daily use?

Yes, based on current evidence. A 2024 28-day RCT found that daily L-theanine supplementation was safe and well tolerated in healthy adults [6]. Both sleep meta-analyses concluded that 200–450 mg/day appears safe [1, 4]. L-theanine has GRAS status in the United States. Long-term safety data beyond 28–90 days are limited.

How does L-theanine compare with L-theanine plus caffeine?

The combined stack has been studied extensively, and several reviews suggest synergistic cognitive benefits—particularly for sustained attention, processing speed, and reaction time. However, the l-theanine cognitive meta evidence also supports benefits from L-theanine alone (particularly the 15 ms reaction time improvement in the 2025 meta-analysis [2] and the 0.51 SMD choice reaction time finding in the 2026 analysis [3]). L-theanine alone is not cognitively inert, but the combination may amplify effects in certain domains.

Are benefits seen in healthy adults only, or also in clinical populations?

The majority of meta-analysis data comes from healthy adults. A 2024 systematic review found potential benefits in clinical populations (schizophrenia, anxiety disorders, ADHD), but the evidence base was 11 studies across three diagnoses—too small to draw firm conclusions [5]. In psychiatric settings, L-theanine has primarily been studied as an adjunct to standard treatments, not as a standalone therapy.

What do 2024–2026 reviews say about the certainty of evidence?

Honestly: the certainty is low to very low for cognitive outcomes (2025 meta-analysis [2]) and low to moderate for sleep outcomes (2024 meta-analysis [1]). Multiple reviews noted small constituent trial sizes, heterogeneous outcome measures, and risk of bias concerns. The direction of effects is consistent and encouraging; the precision of those estimates is not yet high enough to anchor strong clinical recommendations. This is a genuinely emerging evidence base, not a settled one.

Summary and Bottom Line

The L-theanine meta-analysis evidence review landscape has matured substantially between 2024 and 2026. We now have multiple independent pooled analyses covering sleep, cognition, stress, and psychiatric outcomes—enough to move beyond single-study interpretations and draw some reasonably grounded conclusions.

What the Evidence Supports:

Sleep quality: Small but statistically significant improvements in sleep onset latency, daytime dysfunction, and overall sleep quality across a pooled sample of nearly 900 participants. A dose of 200–450 mg/day appears effective and safe for healthy adults based on two independent meta-analyses.

Cognitive performance: A medium-sized effect on choice reaction time (SMD 0.51) from a 200 mg acute dose, and a statistically significant improvement in visual reaction time (~15 ms faster) from a dose-dependent analysis. These are encouraging findings tempered by low-to-very-low certainty ratings.

Acute stress reduction: A modest but detectable effect (SMD 0.31) from 200 mg taken approximately 30–60 minutes before a stressor. Not sedation—no significant fatigue effect was found.

Clinical populations: Preliminary signal of benefit in schizophrenia (adjunctive), anxiety disorders, and ADHD from a small evidence base. Not sufficient to support recommendations outside standard treatment frameworks.

What the Evidence Does Not Support:

• Dramatic anxiolytic effects comparable to pharmaceutical interventions
• Strong effects on mood or fatigue in healthy adults
• Clear cognitive benefits beyond reaction time and sustained attention at this stage
• High-certainty conclusions in most domains

The Overall Verdict:

L-theanine is a well-tolerated, modestly effective compound with a growing and increasingly rigorous evidence base. It is not a panacea. It is not a sedative. It is not a pharmaceutical-grade anxiolytic. What it appears to be—based on the best available l-theanine evidence synthesis from 2024 to 2026—is a safe, relatively low-cost intervention that produces small-to-moderate improvements in sleep quality, acute attention, and stress reactivity in healthy adults at 200–450 mg/day.

For anyone evaluating this compound seriously, the message from the theanine research review literature is: the effects are real, the effect sizes are modest, the certainty is improving but not yet high, and the safety profile is favorable. That is a reasonable scientific foundation for personal decision-making—and a clear-eyed departure from both breathless marketing claims and reflexive skepticism.

References

[1] Loughman A, et al. The effects of L-theanine consumption on sleep outcomes: a systematic review and meta-analysis. Sleep Medicine Reviews. 2024.

[2] Kujawska M, et al. Promising, but Not Completely Conclusive—The Effect of l-Theanine on Cognitive Function in Healthy Individuals: a systematic review and meta-analysis. 2025.

[3] [Authors]. Cognitive and affective effects of L-Theanine: a systematic review and meta-analysis of 31 randomized trials. 2026.

[4] [Authors]. Examining the effect of L-theanine on sleep: a systematic review and meta-analysis / Effects of L-theanine on cognition, mood and sleep. Frontiers. 2025–2026.

[5] [Authors]. The effects of L-theanine supplementation on the outcomes of patients with mental disorders: a systematic review. 2024.

[6] [Authors]. Safety and Efficacy of AlphaWave l-Theanine in Healthy Adults with Moderate Stress: a randomized, double-blind, placebo-controlled clinical trial. 2024.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before beginning any supplementation regimen, particularly if you have a diagnosed health condition or take prescription medications.